
About Bausch Health
Bausch Health is a publicly listed company based in Laval (Canada) founded in 1960. Therapeutics for multiple diseases including dermatology and neurology are developed. The company has 20,700 employees. Bausch Health has completed 19 acquisitions, including Aton Pharma, Bausch & Lomb and DURECT. Its chief executive, as recorded, is Joseph Papa. Its website bauschhealth.com draws about 32 thousand monthly visits. Bausch Health offers products and services including Gastrointestinal Products, Dermatology Products, and Vision Care Products. Its focus areas include Life Sciences, Gastroenterology, Drugs and Diversified. Its legal entity is Bausch Health Companies Inc.
Company details
Founded in 1960 and headquartered in Laval, Canada, operations focus on the pharmaceutical sector where therapeutics are developed for conditions in dermatology, gastrointestinal disorders, eye health, neurology, and other areas. Products such as the lead candidate IDP-120 for acne treatment are manufactured. In 2023, annual revenues of 8.15 billion were recorded alongside a net loss of 0.36 billion.
- Headquarters Laval, Canada
- Employees 20,700
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website bauschhealth.com
- Social LinkedIn X
- Legal Name Bausch Health Companies Inc.
- Annual Revenue$10.47 B (USD)8.79as on Dec 31, 2025
- Net Profit$160.22 M (USD)as on Dec 31, 2025
- EBITDA$3.46 B (USD)10.88as on Dec 31, 2025
- Latest Funding Round$500M (USD), Debt – Conventional
Mar 2019
- Investors
- Employee Count20,700
- Investments & AcquisitionsAton Pharma
& 18 more
Products & Services of Bausch Health
Bausch Health offers a comprehensive portfolio of products and services, including Gastrointestinal Products, Dermatology Products, and Vision Care Products.
Treats gastrointestinal disorders with innovative medications.
Provides solutions for skin conditions and aesthetic treatments.
Offers eye care solutions including devices and pharmaceuticals.
Funding Insights of Bausch Health
- Total Rounds 11
- Last Round Debt – Conventional — $500M
- First Round $14.53M
(Mar 2002)
- Investors Count 1
Latest 10 of 11 funding rounds of Bausch Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | $500M | Debt – Conventional | – | – | – |
| Nov 2018 | $1.5B | Debt – Conventional | – | – | – |
| Jun 2018 | $5.79B | Debt – Conventional | – | – | – |
| Jun 2018 | Debt – Conventional | – | – | – | |
| Apr 2015 | $5.55B | Debt – Conventional | – | – | – |
| Mar 2015 | $10.09B | Debt – Conventional | – | – | – |
| Sep 2012 | $2.25B | Debt – Conventional | – | – | – |
| May 2009 | $365M | Debt – Conventional | – | – | – |
| Jun 2006 | Post-IPO | – | – | ||
| Nov 2003 | $200M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in Bausch Health
Bausch Health has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ValueAct Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm based out of USA | valueact.com | San Francisco, United States |
Investor details for Bausch Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bausch Health
552 people are tracked at Bausch Health (229 in leadership, 323 in team); the tracked headcount is 20,700.
| Name | Role | Group |
|---|---|---|
Joseph Papa | CEO | Leadership |
Pablo Marotta | Senior Director, Strategic Pricing – Us/global | Leadership |
Richard Nagelberg | Director | Leadership |
Paul Schmidt | Director, Regional Accounts | Leadership |
Monika Beckmann | Executive Director, Project Management | Leadership |
Margie St.julien-Valbrun | Director | Leadership |
Kendra Grichuhin | Director Of Regulatory Affairs | Leadership |
Amy Cairns | General Manager, Bausch Health Canada | Leadership |
Jessica Stow | Director, Commercial Litigation And Government Investigations | Leadership |
Ryszard Bukowski | Finance Director Of Manufacturing And Supply Chain - Emena Region | Leadership |
Fernando Zarate | VP, Latin America | Leadership |
Laimonas Ratkus | Finance Director CIS Countries/bulgaria/romania/greece | Leadership |
Jean-Jacques Charhon | Executive Vice President & Chief Financial Officer | Leadership |
Mario Enrique Perez Molina | Director Of Commercial Operations | Leadership |
Dan Ewing | Sr. National Account Director | Leadership |
Alexander Bariso | Director Of Finance, R&d | Leadership |
Martin Roy | Director Of Information Technology | Leadership |
Jinsoo Lee | Director, Global Regulatory Operations | Leadership |
Erik Miao | Director Human Resources,china - Solta Medical | Leadership |
Nicole Rawnsley | Associate Director, MSL Field Strategy, Tactics And Training | Leadership |
532 more people are available in the full profile.
Complete people profiles for Bausch Health
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Bausch Health
Bausch Health is a publicly listed company on the TSX with ticker symbol BHC in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Jan 1999
- Listed onNYSE: BHC
- Listed entityBausch Health Companies Inc.
- Exchange sectorHealth technology
- ISINCA0717341071
- Share price8.36 CAD (-3.24% on the day) · 2026-10-13
- Market capitalisation3,126,561,037.00 CAD
- Price to earnings6.7
- EPS (diluted, trailing year)-4.06 CAD
- Volume (last session)474,866
Financials of Bausch Health
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 14.34B CAD | 219.4M CAD | 4.74B CAD |
| 2024 | 13.19B CAD | -63.0M CAD | 4.28B CAD |
| 2023 | 11.82B CAD | -799.0M CAD | 3.87B CAD |
| 2022 | 10.58B CAD | -292.9M CAD | 3.63B CAD |
| 2021 | 10.57B CAD | -1.19B CAD | 3.92B CAD |
Detailed financial statements for Bausch Health
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bausch Health
Bausch Health has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Aton Pharma, Bausch & Lomb and DURECT.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of therapeutics for chronic diseases and pain | durect.com | Cupertino, United States | 1998 | Jul 2025 | •••• | |
Provider of an augmented reality marketing platform | paragonar.com | Colombo, Sri Lanka | 2015 | Feb 2017 | •••• | |
Manufacturer of OTC drugs | euvipharm.com | 2005 | Jan 2017 | $7.44M | ||
Drugs for hypoactive sexual desire disorder in women are developed. | sproutpharmaceuticals.com | Raleigh, United States | 2011 | Aug 2015 | $1B | |
Provider of eye care products like corneal reshaping products, contact lenses & others | paragonvision.com | Gilbert, United States | 1976 | May 2015 | •••• | |
Specialty pharmaceutical company focusing on prevention and treatment of gastrointestinal (GI) disorders. | salix.com | Bridgewater, United States | 1989 | Feb 2015 | $15.8B | |
Dermatology products are developed, manufactured, and marketed by PreCision Dermatology. | precisionderm.com | Cumberland, United States | 2010 | Feb 2014 | $475M | |
Energy-based aesthetic medical devices are designed and marketed. | solta.com | Hayward, United States | 1995 | Dec 2013 | $250M | |
Pharmaceutical ingredients and formulations are manufactured under contract. | euvipharm.com.vn | Long An, Vietnam | 2005 | Jun 2013 | •••• | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | bausch.com | Bridgewater, United States | 1853 | May 2013 | $8.7B |
Complete acquisition details for Bausch Health
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Bausch Health
14 dated milestones of Bausch Health across 65 years, from founding to its latest funding, stage changes and deals.
- Founded Bausch Health is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $14.5M.
- Acquisition Acquires Bausch & Lomb.
- Acquisition Acquires Euvipharm.
- Acquisition Acquires Solta.
- Acquisition Acquires PreCision Dermatology.
- Acquisition Acquires Salix Pharmaceuticals.
- Acquisition Acquires Paragon Vision Sciences.
- Acquisition Acquires Sprout Pharmaceuticals.
- Acquisition Acquires Euvipharm Pharmaceutical.
- Acquisition Acquires Paragon AR.
- Funding Latest funding round, Debt – Conventional, of $500.0M.
- Acquisition Acquires DURECT.
Web traffic of Bausch Health
The website of Bausch Health (bauschhealth.com) receives about 32.2K visits a month and ranks #988,502 among all websites worldwide, #1,205 in Biotechnology and Pharmaceuticals.
- Monthly visits32.2K
▲ 18.2% vs previous month
- Unique visitors13.7K
per month
- Global rank#988,502
among all websites
- Category rank#1,205
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit2.2
- Average visit37 sec
- DevicesDesktop 44% · Mobile 56%
Websites whose visitors overlap most with Bausch Health. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| organon.com | 100% | #267,781 | View details | ||
| takeda.com | 100% | 620.1K | #93,966 | View details | |
| alfasigma.com | 80% | 55.2K | #605,770 | View details | |
| datumdental.com | 75% | 3.1K | #7,298,366 | View details | |
| bausch.com | 69% | 175.4K | #271,734 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Bausch Health
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bausch Health
Complete news archive for Bausch Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bausch Health
Bausch Health was founded in 1960 and raised its 1st funding round 42 years after it was founded.
Bausch Health is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
Joseph Papa is the CEO of Bausch Health, as recorded in our data.
Bausch Health has 20,700 employees.
Annual revenue of Bausch Health is $10.47B as on Dec 31, 2025.
Founded in 1960 and headquartered in Laval, Canada, operations focus on the pharmaceutical sector where therapeutics are developed for conditions in dermatology, gastrointestinal disorders, eye health, neurology, and other areas. Products such as the lead candidate IDP-120 for acne treatment are manufactured. In 2023, annual revenues of 8.15 billion were recorded alongside a net loss of 0.36 billion.
Bausch Health offers Gastrointestinal Products, Dermatology Products, and Vision Care Products.
Yes, Bausch Health is publicly traded on TSX under the ticker symbol BHC.
Bausch Health has made 19 acquisitions, including Aton Pharma, Bausch & Lomb, and DURECT.
Bausch Health has 1 investor. Key investors include ValueAct Capital.
Bausch Health operates through Bausch Health Companies Inc..
